IL12-mediated signaling events

No Pathway Network information available for IL12-mediated signaling events

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with IL12-mediated signaling events SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Oligoarticular juvenile idiopathic arthritisEnrichmentCD247, IL2RA, IL2RB, STAT47.95
2Rheumatoid factor-negative juvenile idiopathic arthritisEnrichmentCD247, IL2RA, IL2RB, STAT47.95
3T-b+ severe combined immunodeficiency due to cd3delta/cd3epsilon/cd3zetaEnrichmentCD247, CD3D, CD3E7.27
4Severe combined immunodeficiencyEnrichmentCD247, CD3D, CD3E, CD3G, IKBKB6.83
5Breast implant-associated anaplastic large cell lymphomaEnrichmentJAK2, STAT34.37
6Immunodeficiency 7EnrichmentTRA, TRAC4.37
7Hepatitis c virusEnrichmentCCR5, IFNG4.25
8Human immunodeficiency virus type 1EnrichmentCCL3, CCR5, IFNG4.22
9Pediatric systemic lupus erythematosusEnrichmentIRAK1, STAT44.07
10Common variable immunodeficiencyEnrichmentNFKB1, NFKB23.52
11Primary biliary cholangitisEnrichmentIL12A, IL12RB13.29
12Behcet syndromeEnrichmentIL12A, STAT42.63
13Diffuse large b-cell lymphomaEnrichmentSOCS1, STAT32.52
14Precursor t-cell acute lymphoblastic leukemiaEnrichmentTRA, TRB2.46
15Immunodeficiency 35EnrichmentTYK22.42
16Immunodeficiency 30EnrichmentIL12RB12.42
17Fetal encasement syndromeEnrichmentCHUK2.42
18Immunodeficiency 15bEnrichmentIKBKB2.42
19Immunodeficiency 69EnrichmentIFNG2.42
20Immunodeficiency 15aEnrichmentIKBKB2.42
21Immunodeficiency 92EnrichmentREL2.42
22Disabling pansclerotic morphea of childhoodEnrichmentSTAT42.42
23T-cell large granular lymphocyte leukemiaEnrichmentSTAT32.42
24Immunodeficiency 18EnrichmentCD3E2.42
25Systemic lupus erythematosus 11EnrichmentSTAT42.42
26Immunodeficiency 25EnrichmentCD2472.42
27Immunodeficiency 29EnrichmentIL12B2.42
28Autoimmune disease, multisystem, infantile-onset, 1EnrichmentSTAT32.42
29Deficiency in anterior pituitary function - variable immunodeficiency syndromeEnrichmentNFKB22.42
30Immunodeficiency 53EnrichmentRELB2.42
31Bartsocas-papas syndrome 2EnrichmentCHUK2.42
32Immunodeficiency 88EnrichmentTBX212.42
33Immunodeficiency 19, severe combinedEnrichmentCD3D2.42
34Immunodeficiency 112EnrichmentMAP3K142.42
35Stat3-related early-onset multisystem autoimmune diseaseEnrichmentSTAT32.42
36Combined immunodeficiency-hypogammaglobulinemia-skeletal anomalies syndrome due to ikbka deficiencyEnrichmentCHUK2.42
37Immunodeficiency 19EnrichmentCD3D2.42
38Chronic lymphoproliferative disorder of natural killer cellsEnrichmentSTAT32.42
39Nik deficiencyEnrichmentMAP3K142.42
40Type 1 diabetes mellitus 10EnrichmentIL2RA2.36
41Immunodeficiency 116EnrichmentCD8A2.36
42Immunodeficiency 43EnrichmentB2M2.36
43Hyper-ige syndrome 6, autosomal dominant, with recurrent infectionsEnrichmentSTAT62.36
44Immunodeficiency 63 with lymphoproliferation and autoimmunityEnrichmentIL2RB2.36
45Charcot-marie-tooth disease, axonal, type 2bEnrichmentRAB7A2.36
46Okt4 epitope deficiencyEnrichmentCD42.36
47Charcot-marie-tooth disease type 2bEnrichmentRAB7A2.36
48Dialysis-related amyloidosisEnrichmentB2M2.36
49Chronic recurrent multifocal osteomyelitis 3EnrichmentIL1R12.36
50Birdshot chorioretinopathyEnrichmentHLA-A2.36
51Immunodeficiency 31aEnrichmentSTAT12.36
52Graham little-piccardi-lassueur syndromeEnrichmentHLA-DRA2.36
53Immunodeficiency 31bEnrichmentSTAT12.36
54Type 1 diabetes mellitus 22EnrichmentCCR52.36
55Immunodeficiency 22EnrichmentLCK2.36
56Immunodeficiency 79EnrichmentCD42.36
57Amyloidosis, hereditary systemic 6EnrichmentB2M2.36
58Diaphragmatic hernia-short bowel-asplenia syndromeEnrichmentHLX2.36
59Microcephaly-polymicrogyria-corpus callosum agenesis syndromeEnrichmentEOMES2.36
60Ectodermal dysplasia and immunodeficiency 2EnrichmentNFKBIA2.12
61Immunodeficiency, common variable, 12, with autoimmunityEnrichmentNFKB12.12
62Immunodeficiency, common variable, 10EnrichmentNFKB22.12
63Thrombocythemia 3EnrichmentJAK22.12
64Autoinflammatory disease, familial, behcet-like 3EnrichmentRELA2.12
65Rela fusion-positive ependymomaEnrichmentRELA2.12
66Ectodermal dysplasia and immune deficiencyEnrichmentNFKBIA2.12
67Trypsinogen deficiencyEnrichmentTRB2.12
68Immunodeficiency 17EnrichmentCD3G2.12
69PolycythemiaEnrichmentJAK22.12
70Lymphomatoid papulosisEnrichmentTYK22.12
71Hypereosinophilic syndromeEnrichmentJAK22.12
72Common variable immunodeficiency 12EnrichmentNFKB12.12
73Primary cutaneous anaplastic large cell lymphomaEnrichmentTYK22.12
74Hemangiopericytoma, malignantEnrichmentSTAT62.06
75West nile virusEnrichmentCCR52.06
76Severe cutaneous adverse reactionEnrichmentHLA-A2.06
77Immunodeficiency 41 with lymphoproliferation and autoimmunityEnrichmentIL2RA2.06
78Immunodeficiency 31cEnrichmentSTAT12.06
79Cebalid syndromeEnrichmentMTOR2.06
80Smith-kingsmore syndromeEnrichmentMTOR2.06
81Systemic lupus erythematosusEnrichmentIRAK1, STAT42.01
82Hyper-ige syndrome 1, autosomal dominant, with recurrent infectionsEnrichmentSTAT31.94
83Asthma, nasal polyps, and aspirin intoleranceEnrichmentTBX211.94
84Takayasu arteritisEnrichmentIL12B1.94
85Polycythemia veraEnrichmentJAK21.94
86Tuberous sclerosis 1EnrichmentIFNG1.94
87Nasopharyngeal carcinomaEnrichmentNFKBIA1.94
88Tuberous sclerosis 2EnrichmentIFNG1.94
89Hyper ige syndromeEnrichmentSTAT31.94
90Immune thrombocytopeniaEnrichmentSOCS11.89
91Immunodeficiency 98 with autoinflammation, x-linkedEnrichmentFASLG1.89
92Severe combined immunodeficiency, x-linkedEnrichmentIL2RG1.89
93Combined immunodeficiency, x-linkedEnrichmentIL2RG1.89
94Autoinflammatory syndrome, familial, with or without immunodeficiencyEnrichmentSOCS11.89
95Erythrocytosis, familial, 1EnrichmentJAK21.82
96Budd-chiari syndromeEnrichmentJAK21.82
97Immunodeficiency, common variable, 1EnrichmentNFKB21.82
98Anemia, autoimmune hemolyticEnrichmentSOCS11.76
99Autoimmune lymphoproliferative syndromeEnrichmentFASLG1.76
100Focal cortical dysplasia, type iiEnrichmentMTOR1.76
101Congenital generalized lipodystrophyEnrichmentFOS1.76
102Immunodeficiency by defective expression of mhc class iEnrichmentB2M1.76
103Isolated focal cortical dysplasia type iiEnrichmentMTOR1.76
104Ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominantEnrichmentTRAF61.72
105Vitamin d-dependent rickets, type 2aEnrichmentTRB1.72
106Myeloproliferative neoplasmEnrichmentJAK21.72
107Idiopathic aplastic anemiaEnrichmentIFNG1.72
108Amyloidosis, hereditary systemic 2EnrichmentB2M1.67
109Histiocytoid hemangiomaEnrichmentFOS1.67
110HemimegalencephalyEnrichmentMTOR1.67
111Chronic mucocutaneous candidiasisEnrichmentSTAT11.59
112MyelofibrosisEnrichmentJAK21.58
113Essential thrombocythemiaEnrichmentJAK21.58
114Renal cell carcinoma, papillary, 1EnrichmentMTOR1.52
115Overgrowth syndromeEnrichmentMTOR1.52
116Lennox-gastaut syndromeEnrichmentMAPK101.52
117Permanent neonatal diabetes mellitusEnrichmentSTAT31.52
118Leukemia, acute lymphoblastic 3EnrichmentJAK21.47
119Lymphoma, non-hodgkin, familialEnrichmentB2M1.46
120Ciliary dyskinesia, primary, 3EnrichmentNFKB11.42
121Aplastic anemiaEnrichmentIFNG1.42
122Omenn syndromeEnrichmentIL2RG1.37
123Combined immunodeficiencyEnrichmentIL2RG1.33
124IchthyosisEnrichmentIL2RB1.33
125Combined t cell and b cell immunodeficiencyEnrichmentIL2RG1.33
126Combined t and b cell immunodeficiencyEnrichmentIL2RG1.33
127Acute promyelocytic leukemiaEnrichmentSTAT31.31
128Hereditary chronic pancreatitisEnrichmentTRB1.28
129GliosarcomaEnrichmentNFKBIA1.22
130Pancreatitis, hereditaryEnrichmentTRB1.20
131Giant cell glioblastomaEnrichmentNFKBIA1.20
132Renal cell carcinoma, nonpapillaryEnrichmentMTOR1.20
133Rare genetic intellectual disabilityEnrichmentMTOR1.20
134MalariaEnrichmentNOS21.07
135Severe covid-19EnrichmentHLA-A0.92
136Lung cancerEnrichmentFASLG0.88
137Leukemia, acute myeloidEnrichmentJAK20.85
138Gastric cancerEnrichmentIL1B0.77
139Primary ovarian insufficiencyEnrichmentJAK20.69
140Breast cancerEnrichmentJUN0.60

Loading...
Loading...
Loading...